Marjorie Green
About
In The Last Decade
Marjorie Green
15 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 2.5k
- Oncology 2.5k
- Molecular Biology 971
- Pathology and Forensic Medicine 847
- Pulmonary and Respiratory Medicine 650
Countries citing papers authored by Marjorie Green
This map shows the geographic impact of Marjorie Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Green more than expected).
Fields of papers citing papers by Marjorie Green
This network shows the impact of papers produced by Marjorie Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Green. The network helps show where Marjorie Green may publish in the future.
Co-authorship network of co-authors of Marjorie Green
This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Green. A scholar is included among the top collaborators of Marjorie Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Green. Marjorie Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 47 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 69 | |
| 7 | Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer breakdown → | 2191 |
| 8 | 80 | |
| 9 | Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy breakdown → | 1078 |
| 10 | 19 | |
| 11 | 323 | |
| 12 | 117 | |
| 13 | Neoadjuvant chemotherapy for operable breast cancer. | 27 |
| 14 | 44 | |
| 15 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.